{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:44:21Z","timestamp":1771022661631,"version":"3.50.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 71-year-old man was referred for <jats:sup>177<\/jats:sup>Lu-PSMA therapy. He had metastatic castration-resistant prostate cancer, progressive on several treatment lines, with current PSA 260 \u03bcg\/L and deteriorating condition. CT showed ascites with omental and peritoneal metastases, all positive on PSMA PET\/CT. He was treated with 4 cycles of 7.4 GBq (0.2 Ci) <jats:sup>177<\/jats:sup>Lu-PSMA-I&amp;T. Posttherapy scans showed good targeting of all metastases. After 4 cycles, PSA had dropped to 44 \u03bc\/L. Four months after the fourth cycle, the patients\u2019 general condition had significantly improved, and PSA had decreased to 7.0 \u03bcg\/L.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004577","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T23:20:31Z","timestamp":1675120831000},"page":"422-425","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Peritoneal Metastases From Prostate Carcinoma Treated With 177Lu-PSMA-I&amp;T"],"prefix":"10.1097","volume":"48","author":[{"given":"Larissa W.","family":"van Golen","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Antoni van Leeuwenhoek, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom T.P.","family":"Seijkens","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Antoni van Leeuwenhoek, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeantine M.","family":"de Feijter","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Antoni van Leeuwenhoek, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Vogel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Antoni van Leeuwenhoek, Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"FSO707","DOI":"10.2144\/fsoa-2021-0009","article-title":"Isolated peritoneal carcinomatosis in prostate cancer: from a successful hormonal management to a review of the literature","volume":"7","year":"2021","journal-title":"Future Sci OA"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.3390\/curroncol29070351","article-title":"Isolated peritoneal metastasis of prostate cancer presenting with massive ascites: a case report","volume":"29","year":"2022","journal-title":"Curr Oncol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1097\/RLU.0000000000003414","article-title":"Rapidly evolving diffuse omental carcinomatosis of prostate cancer in 68Ga-PSMA PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/RLU.0000000000002843","article-title":"Detection of unusual peritoneal metastases of prostate cancer with 68Ga\u2013prostate-specific membrane antigen PET\/CT","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/RLU.0000000000003802","article-title":"Detection of diffuse peritoneal and omental metastases from prostate cancer with 18F PSMA-1007 PET\/CT","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","first-page":"312","article-title":"Is 177Lu-PSMA an effective treatment modality for mCRPC patients with bone and visceral metastasis?","volume":"23","year":"2020","journal-title":"Hell J Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/RLU.0000000000003307","article-title":"Visceral metastases as predictors of response and survival outcomes in patients of castration-resistant prostate cancer treated with 177Lu-labeled prostate-specific membrane antigen radioligand therapy: a systematic review and meta-analysis","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1200\/JCO.2022.40.16_suppl.5002","article-title":"[68Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [177Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy","volume":"40","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:02:18Z","timestamp":1750532538000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004577","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}